GFM Network News


Pressure on for Bayer CEO to fix legal problems as chairman quits

Reading Time: 2 minutes Frankfurt | Reuters — The departure of Bayer chairman Werner Wenning will turn up the heat on CEO Werner Baumann to resolve the healthcare to agriculture group’s legal problems, two of the firm’s biggest German shareholders said on Wednesday. Bayer’s shares have plunged about a quarter in value since August 2018, when the company lost […] Read more

Bayer considers new tactic in Roundup settlement talks

Reading Time: 5 minutes Reuters — As Bayer tries to settle U.S. lawsuits claiming that its Roundup herbicide causes cancer, the company is considering a proposal that would bar plaintiffs’ lawyers involved in the litigation from advertising for new clients, according to a person familiar with the matter. Bayer has said it is engaged in mediation to resolve the […] Read more


K+S cuts output on weak potash demand

Reading Time: < 1 minute Frankfurt | Reuters — German mineral miner K+S will cut production of potash fertilizers, dragging core earnings lower, as a halt imposed by China on potash imports dampens global markets. “In the current weak market environment, which is further intensified by the continuing Chinese import bans on the standard potassium chloride product, adjusting production is […] Read more

Elanco to become No. 2 in animal health with Bayer deal

Reading Time: 3 minutes Reuters — Elanco Animal Health agreed to buy Bayer’s veterinary drugs unit on Tuesday in a cash and stock deal valued at US$7.6 billion (C$10 billion), creating the second largest maker of medicines for livestock and pets and expanding Elanco’s reach online. The deal is the latest in the fast-growing animal health market, which has […] Read more



Investors call for reprieve for Bayer bosses after AGM rebuke

Reading Time: 2 minutes Frankfurt | Reuters — Three of Bayer’s largest German investors said the drugmaker’s embattled management needed to stay at the helm to avoid further upheaval, despite their unease over a share price slump in the wake of the US$63 billion Monsanto takeover. The backing for CEO Werner Baumann comes after an unprecedented rebuke at the […] Read more


Bayer shareholders vent ire over Monsanto-linked stock rout

Reading Time: 2 minutes Bonn | Reuters — Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker’s US$63 billion takeover of seed and chemical firm Monsanto. Several large investors said they will not support aspirin invesotr Bayer’s management in a key vote scheduled for the end of its […] Read more

Bayer reaps profit lift from Monsanto

Reading Time: 2 minutes Leverkusen, Germany | Reuters –– Bayer’s US$63 billion purchase of seed and chemical firm Monsanto made its mark on the German company’s fourth quarter earnings on Wednesday, lifting profit and boding well for the peak season of its enlarged agriculture business. However, mounting litigation risks related to Monsanto still cast a pall over an adjusted […] Read more



Ag trade flows may change amid trade dispute, Bayer says

Reading Time: 2 minutes Monheim | Reuters — Bayer said on Tuesday it would be difficult to predict 2019 earnings at its agriculture business, which now includes Monsanto, because a U.S.-Chinese trade dispute could reroute global trade flows in farming commodities. The head of Bayer’s crop science division told Reuters his company could even benefit if U.S. farmers switched […] Read more